These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists. Modjtahedi H; Dean C Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293 [TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of a novel growth factor from human breast cancer cells. Lupu R; Wellstein A; Sheridan J; Ennis BW; Zugmaier G; Katz D; Lippman ME; Dickson RB Biochemistry; 1992 Aug; 31(32):7330-40. PubMed ID: 1324710 [TBL] [Abstract][Full Text] [Related]
9. Use of erbstatin as protein-tyrosine kinase inhibitor. Umezawa K; Imoto M Methods Enzymol; 1991; 201():379-85. PubMed ID: 1658555 [No Abstract] [Full Text] [Related]
10. Constrained peptide analogues of transforming growth factor-alpha residues cysteine 21-32 are mitogenically active. Use of proline mimetics to enhance biological potency. Chamberlin SG; Sargood KJ; Richter A; Mellor JM; Anderson DW; Richards NG; Turner DL; Sharma RP; Alexander P; Davies DE J Biol Chem; 1995 Sep; 270(36):21062-7. PubMed ID: 7673134 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity study of myxoma virus growth factor. Lin YZ; Ke XH; Tam JP Biochemistry; 1991 Apr; 30(13):3310-4. PubMed ID: 2009268 [TBL] [Abstract][Full Text] [Related]
12. A kinase associated with chromatin that can be activated by ligand-p185c-Neu or epidermal growth factor-receptor interactions. Samanta A; Greene MI Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6582-6. PubMed ID: 7604037 [TBL] [Abstract][Full Text] [Related]
13. The physiology of transforming growth factor-alpha. Derynck R Adv Cancer Res; 1992; 58():27-52. PubMed ID: 1546559 [No Abstract] [Full Text] [Related]
14. Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF). Shin SY; Shimizu M; Ohtaki T; Munekata E Peptides; 1995; 16(2):205-10. PubMed ID: 7784250 [TBL] [Abstract][Full Text] [Related]
15. Binding specificities and affinities of egf domains for ErbB receptors. Jones JT; Akita RW; Sliwkowski MX FEBS Lett; 1999 Mar; 447(2-3):227-31. PubMed ID: 10214951 [TBL] [Abstract][Full Text] [Related]
16. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD Biochem Biophys Res Commun; 1991 Aug; 178(3):1413-20. PubMed ID: 1678600 [TBL] [Abstract][Full Text] [Related]
17. Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells. Rabiasz GJ; Langdon SP; Bartlett JM; Crew AJ; Miller EP; Scott WN; Smyth JF; Miller WR Br J Cancer; 1992 Aug; 66(2):254-9. PubMed ID: 1503897 [TBL] [Abstract][Full Text] [Related]